Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-02-24

Clinical Trial Update: Red Blood Cell Lifespan

View source ↗

Summary

A clinical trial studying red blood cell lifespan in chronic kidney disease and patients on hemodialysis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Renal Research Institute | Conditions: Chronic Kidney Disease, Hemodialysis | Status: TERMINATED